Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ahmad Karimi Rahjerdi
Observed names:
Ahmad K. Rahjerdi,
Karimi Rahjerdi, Ahmad
Institutions:
Iran University of Medical Sciences,
Stem Cell Technology Research Center
Observed institutions:
Iran University of Medical Sciences,
Stem Cell Technology Research Center,
National Institute of Genetic Engineering and Biotechnology
ORCID:
0000-0001-6017-8482
Observed ORCID:
0000-0001-6017-8482
OpenAlex ID:
A5027199687
Development of Inactivated FAKHRAVAC® Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models
2021
·
Soheil Ghasemi
, Kosar Naderi Saffar
, et al.
·
Vaccines
·
26
PDF
Oral immunization with a plant-derived chimeric protein in mice: Toward the development of a multipotent edible vaccine against E. coli O157: H7 and ETEC
2018
·
Fatemeh Shojaei Jeshvaghani
, Jafar Amani
, et al.
·
Immunobiology
·
23
Designing and structure evaluation of multi-epitope vaccine against ETEC and EHEC, an in silico approach
2015
·
Fatemeh S. jeshvaghani
, Ahmad K. Rahjerdi
, et al.
·
Protein and Peptide Letters
·
14
Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial
2022
·
Mohammadreza Ahi
, Ramin Hamidi Farahani
, et al.
·
Vaccines
·
7
PDF
Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18–70 years
2023
·
Fatemeh Gholami
, Ramin Hamidi Farahani
, et al.
·
BMC Infectious Diseases
·
4
PDF
Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial
2023
·
Masoud Solaymani-Dodaran
, Pouria Basiri
, et al.
·
Virology Journal
·
2
PDF
Immunogenic Evaluation of Bivalent Vaccine Candidate against Enterohemorrhagic and Enterotoxigenic Escherichia coli.
2019
·
Ahmad Karimi Rahjerdi
, Mahyat Jafari
, et al.
·
PubMed
·
2
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18–55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial
2023
·
Akram Ansarifar
, Ramin Hamidi Farahani
, et al.
·
Vaccine X
FAKHRAVAC and BBIBP-CorV vaccine seeds’ binding to angiotensin-converting enzyme 2: A comparative molecular dynamics study
2023
·
Soroush Setareh
, Iman Rad
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Show more works
View as search
Works count:
14
Citation count:
78
H-index:
4
I10-index:
3
Year
Topic
Type